Document Detail


Angiotensin II and sympathetic activity in patients with congestive heart failure.
MedLine Citation:
PMID:  8384645     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: This study was designed to determine the effects of intravenous angiotensin II infusions and the short-term effects of enalaprilat on venous plasma norepinephrine and norepinephrine spillover in patients with stable chronic congestive heart failure. BACKGROUND: Angiotensin II has been shown experimentally to stimulate norepinephrine release. Such effects, if present in humans with congestive heart failure, could be of pathophysiologic and pharmacologic importance. METHODS: In study 1, 60-min angiotensin II (5 ng/kg per min) infusions were administered in eight patients with chronic New York Heart Association functional class II and III congestive heart failure. Heart rate, arterial pressure, forearm venous plasma norepinephrine, norepinephrine clearance (estimated from the clearance of tritiated norepinephrine) and norepinephrine spillover were measured after 30 min in the supine position and after 15 min each of head-up and head-down tilt. All patients were studied in a double-blind manner on two occasions with vehicle control infusions. In study 2, 14 patients comparable to those in the first study had similar measurements made in the supine position before and 30 and 60 min after the administration of enalaprilat (1 mg intravenously). Eight patients received a double-blind vehicle control. RESULTS: In study 1, there were no effects of angiotensin II on heart rate, plasma norepinephrine, norepinephrine clearance or norepinephrine spillover compared with the vehicle control when the patient was in the supine position. Mean arterial pressure increased from 85 +/- 13 to 95 +/- 10 mm Hg with angiotensin II. During upright tilt, plasma norepinephrine and norepinephrine spillover increased comparably with angiotensin II and the vehicle control. During head-down tilt, plasma norepinephrine decreased with both angiotensin II and the vehicle control. Norepinephrine spillover remained elevated relative to control values on both study days during head-down tilt. In study 2, both enalaprilat and vehicle control administration were associated with a slight decrease in mean arterial pressure (5 +/- 2 vs. 3 +/- 4 mm Hg, p = NS), but no changes were seen in plasma norepinephrine. Norepinephrine clearance and spillover decreased comparably with time after both enalaprilat and vehicle control. CONCLUSIONS: Neither the infusion of angiotensin II nor the acute administration of enalaprilat significantly alters the activity of the sympathetic nervous system as reflected by plasma norepinephrine or systemic venous norepinephrine spillover in patients with chronic congestive heart failure. These data weaken the hypothesis that angiotensin II is an important regulator of sympathetic activity in congestive heart failure.
Authors:
S R Goldsmith; G J Hasking; E Miller
Related Documents :
19327775 - Aldosterone blockade by spironolactone improves the hypertensive vascular hypertrophy a...
7629405 - Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiote...
1725025 - Angiotensin ii: vasoconstrictor or growth factor?
11015555 - Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensi...
18031285 - Low-grade inflammation and arterial wave reflection in patients with chronic fatigue sy...
8176605 - Differential effects of inhaled nitric oxide on normoxic and hypoxic isolated in situ n...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  21     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1993 Apr 
Date Detail:
Created Date:  1993-04-29     Completed Date:  1993-04-29     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1107-13     Citation Subset:  AIM; IM; S    
Affiliation:
Hennepin County Medical Center, Cardiology Division, Minneapolis, Minnesota 55415.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Analysis of Variance
Angiotensin II / pharmacology*
Blood Pressure / drug effects
Chronic Disease
Double-Blind Method
Enalaprilat / pharmacology*
Female
Heart Failure / blood,  physiopathology*
Heart Rate / drug effects
Humans
Male
Middle Aged
Norepinephrine / blood*,  physiology
Sympathetic Nervous System / drug effects*
Grant Support
ID/Acronym/Agency:
P01HL32427/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
11128-99-7/Angiotensin II; 51-41-2/Norepinephrine; 84680-54-6/Enalaprilat
Comments/Corrections
Erratum In:
J Am Coll Cardiol 1993 Jul;22(1):342

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epithelial myoepithelial tumour of the tracheal gland.
Next Document:  [A case of malignant fibrous histiocytoma in the thymic carcinoid].